HIV-derived lentiviral particles promote T-cell independent activation and differentiation of naïve cognate conventional B2-cells in vitro

Vaccine

Volumn 31, Issue 44, 2013, Pages 5088-5098

  Gardt, Oliver ^a   Grewe, Bastian ^a   Tippler, Bettina G ^a   Überla, Klaus ^a   Temchura, Vladimir V ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

B cells; Lentiviral VLP; T independent activation

Indexed keywords

CD38 ANTIGEN; CD40 LIGAND; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; L SELECTIN; LYSOZYME; SYNDECAN 1; VIRUS LIKE PARTICLE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INTERNALIZATION; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

B-CELLS; LENTIVIRAL VLP; T-INDEPENDENT ACTIVATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CELL PROLIFERATION; GERMINAL CENTER; HEK293 CELLS; HIV; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MURAMIDASE; RECEPTORS, ANTIGEN, B-CELL; VIRION;

EID: 84885434723     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.055     Document Type: Article

References (46)

1. Grgacic E.V., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
2. Yildiz I., Shukla S., Steinmetz N.F. Applications of viral nanoparticles in medicine. Curr Opin Biotechnol 2011, 6:901-908.
3. Kushnir N., Streatfield S.J., Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 2012, 31:58-63.
4. McBurney S.P., Young K.R., Ross T.M. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology 2007, 358:334-346.
5. Nabi G., Temchura V., Grossmann C., Kuate S., Tenbusch M., Überla K. T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus. Retrovirology 2012, 9:42.
6. Kuate S., Stahl-Hennig C., Stoiber H., Nchinda G., Floto A., Franz M., et al. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology 2006, 351:133-144.
7. Tenbusch M., Ignatius R., Temchura V., Nabi G., Tippler B., Stewart-Jones G., et al. Risk of immunodeficiency virus infection may increase with vaccine-induced immune response. J Virol 2012, 86:10533-10539.
8. Cubas R., Zhang S., Kwon S., Sevick-Muraca E.M., Li M., Chen C., et al. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother 2009, 32:118-128.
9. Szomolanyi-Tsuda E., Le Q.P., Garcea R.L., Welsh R.M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 1998, 72:6665-6670.
10. Schmidt M.R., McGinnes L.W., Kenward S.A., Willems K.N., Woodland R.T., Morrison T.G. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol 2012, 86:11654-11662.
11. Yao Q., Zhang R., Guo L., Li M., Chen C. Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine. J Immunol 2004, 173:1951-1958.
12. Fehr T., Naim H.Y., Bachmann M.F., Ochsenbein A.F., Spielhofer P., Bucher E., et al. T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat Med 1998, 4:945-948.
13. Deml L., Speth C., Dierich M.P., Wolf H., Wagner R. Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol 2005, 42:259-277.
14. Litinskiy M.B., Nardell B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
15. Balázs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002, 17:341-352.
16. Wykes M., MacPherson G. Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 2000, 100:1-3.
17. Yang R., Murillo F.M., Delannoy M.J., Blosser R.L., Yutzy W.H., Uematsu S., et al. B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J Immunol 2005, 174:7912-7919.
18. Zhang S., Cubas R., Li M., Chen C., Yao Q. Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells. Mol Immunol 2009, 46:1988-2001.
19. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med 2003, 197:845-860.
20. Miller J., Germain R.N. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med 1986, 164:1478-1489.
21. Wagner R., Graf M., Bieler K., Wolf H., Grunwald T., Foley P., et al. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors. Hum Gene Ther 2000, 11:2403-2413.
22. Temchura V.V., Tenbusch M., Nchinda G., Nabi G., Tippler B., Zelenyuk M., et al. Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. Vaccine 2008, 26:3662-3672.
23. Schwartz S., Campbel M., Nasioulas G., Harrison J., Felber B.K., Pavlakis G.N. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 1992, 66:7176-7182.
24. Kamdem Toukam D., Tenbusch M., Stang A., Temchura V., Storcksdieck Genannt Bonsmann M., Grewe B., et al. Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus. PLoS One 2012, 7:e38068. 10.1371/journal.pone.0038068.
25. Grewe B., Hoffmann B., Ohs I., Blissenbach M., Brandt S., Tippler B., et al. Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag. J Virol 2012, 86:2990-3002.
26. Grimaldi C.M., Hicks R., Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol 2005, 174:1775-1781.
27. Niiro H., Clark E.A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002, 2:945-956.
28. Laszlo G., Hathcock K.S., Dickle H.B., Hodes R.J. Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells. J Immunol 1993, 150:5252-5262.
29. Nutt S.L., Tarlinton D.M. Germinal center B and follicular helper T cells: siblings, cousins or just good friends. Nat Immunol 2011, 12:472-477.
30. Oliver A.M., Martin F., Kearney J.F. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J Immunol 1997, 158:1108-1115.
31. Stephens R., Ndungu F.M., Langhorne J. Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells. Parasite Immunol 2009, 31:20-31.
32. Marshall J.L., Zhang Y., Pallan L., Hsu M.C., Khan M., Cunningham A.F., et al. Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts. Eur J Immunol 2011, 41:3506-3512.
33. Kuraoka M., McWilliams L., Kelsoe G. AID expression during B-cell development: searching for answers. Immunol Res 2011, 49:3-13.
34. Sverremark E., Fernandez C. Role of T cells and germinal center formation in the generation of immune responses to the thymus-independent carbohydrate dextran B512. J Immunol 1998, 161:4646-4651.
35. Grammer A.C., Bergman M.C., Miura Y., Fujita K., Davis L.S., Lipsky P.E. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995, 154:4996-5010.
36. Wykes M., Poudrier J., Lindstedt R., Gray D. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells. Eur J Immunol 1998, 28:548-559.
37. Chackerian B., Durfee M.R., Schiller J.T. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. J Immunol 2008, 180:5816-5825.
38. Morrison V.L., Bar T.A., Brown S., Gray D. TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection. J Immunol 2010, 185:2737-2746.
39. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 2007, 178:7779-7786.
40. Foy T.M., Laman J.D., Ledbetter J.A., Aruffo A., Claassen E., Noelle R.J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994, 180:157-163.
41. Tarlinton D. B-cell memory: are subsets necessary. Nat Rev Immunol 2006, 6:785-790.
42. Tomayko M.M., Steinel N.C., Anderson S.M., Shlomchik M.J. Cutting edge: hierarchy of maturity of murine memory B cell subsets. J Immunol 2010, 185:7146-7150.
43. Dogan I., Bertocci B., Vilmont V., Delbos F., Mégret J., Storck S., et al. Multiple layers of B cell memory with different effector functions. Nat Immunol 2009, 10:1292-1299.
44. Good-Jacobson K.L., Shlomchik M.J. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol 2010, 185:3117-3125.
45. Saito M., Gao J., Basso K., Kitagawa Y., Smith P.M., Bhagat G., et al. A signalling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007, 12:280-292.
46. Hussain R., Dawood G., Abrar N., Toossi Z., Minai A., Dojki M., et al. Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients. Clin Diagn Lab Immunol 1995, 2:726-732.